 |
7 Diseases |  |
13 Trials |
|
13 Trials |  |
1459 News |  |
| «12...567891011121314151617 |
- | Ajovy (fremanezumab) / Otsuka, Teva
Trial completion, Trial primary completion date: Safety and Bioavailability of IV and SC LBR-101 (clinicaltrials.gov) - Mar 5, 2015
P1, N=36, Completed, Sponsor: Teva Pharmaceutical Industries
Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Dec 2014
- ||| Ajovy (fremanezumab) / Otsuka, Teva
Enrollment closed: A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine (clinicaltrials.gov) - Nov 20, 2014
P2, N=270, Active, not recruiting, Sponsor: Teva Pharmaceutical Industries
Active, not recruiting --> Completed | Trial primary completion date: Dec 2013 --> Dec 2014 Recruiting --> Active, not recruiting
- ||| Ajovy (fremanezumab) / Otsuka, Teva
Enrollment closed: Assessment of LBR-101 In Chronic Migraine (clinicaltrials.gov) - Oct 4, 2014
P2, N=225, Active, not recruiting, Sponsor: Teva Pharmaceutical Industries
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- |||| Ajovy (fremanezumab) / Otsuka, Teva
Enrollment open: A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine (clinicaltrials.gov) - Jan 7, 2014
P2, N=270, Recruiting, Sponsor: Labrys Biologics Inc.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- |||| Ajovy (fremanezumab) / Otsuka, Teva
Enrollment open: Assessment of LBR-101 In Chronic Migraine (clinicaltrials.gov) - Jan 7, 2014
P2, N=225, Recruiting, Sponsor: Labrys Biologics Inc.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- ||||| Ajovy (fremanezumab) / Otsuka, Teva
New P2 trial: A Multicenter Assessment of LBR-101 in High Frequency Episodic Migraine (clinicaltrials.gov) - Dec 30, 2013
P2, N=270, Recruiting, Sponsor: Labrys Biologics Inc.
- ||||| Ajovy (fremanezumab) / Otsuka, Teva
New P2 trial: Assessment of LBR-101 In Chronic Migraine (clinicaltrials.gov) - Dec 25, 2013
P2, N=225, Recruiting, Sponsor: Labrys Biologics Inc.
- Ajovy (fremanezumab) / Otsuka, Teva
Enrollment closed: Safety and Bioavailability of IV and SC LBR-101 (clinicaltrials.gov) - Dec 19, 2013
P1, N=36, Active, not recruiting, Sponsor: Labrys Biologics Inc.
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- | Ajovy (fremanezumab) / Otsuka, Teva
New P1 trial: Safety and Bioavailability of IV and SC LBR-101 (clinicaltrials.gov) - Nov 21, 2013
P1, N=36, Active, not recruiting, Sponsor: Labrys Biologics Inc.
- | Ajovy (fremanezumab) / Otsuka, Teva
Trial completion: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers (clinicaltrials.gov) - Feb 19, 2013
P1, N=31, Completed, Sponsor: Pfizer
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Ajovy (fremanezumab) / Otsuka, Teva
Trial completion: A Clinical Study Evaluating The Safety And Tolerability Of PF-04427429 In Healthy Adult Volunteers. The Pharmacokinetics And Pharmacodynamics Of PF-04427429 Will Also Be Investigated (clinicaltrials.gov) - Feb 20, 2012
P1, N=21, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed Recruiting --> Completed
- | Ajovy (fremanezumab) / Otsuka, Teva
New P1 trial: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study Of PF-04427429 In Healthy Women Volunteers (clinicaltrials.gov) - Jan 16, 2012
P1, N=31, Completed, Sponsor: Pfizer
- | Ajovy (fremanezumab) / Otsuka, Teva
Trial completion: Study In Healthy Adult Volunteers To Evaluate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of PF-04427429 (clinicaltrials.gov) - Jan 16, 2012
P1, N=40, Completed, Sponsor: Pfizer
Recruiting --> Completed Recruiting --> Completed
- Emla-cream / Akorn, AstraZeneca, Ajovy (fremanezumab) / Otsuka, Teva
Enrollment change: Acute Response Capsaicin Flare Study (clinicaltrials.gov) - Dec 19, 2011
P1, N=12, Completed, Sponsor: Pfizer
Recruiting --> Completed N=24 --> 12
- | Emla-cream / Akorn, AstraZeneca, Ajovy (fremanezumab) / Otsuka, Teva
Trial completion: Acute Response Capsaicin Flare Study (clinicaltrials.gov) - Dec 19, 2011
P1, N=12, Completed, Sponsor: Pfizer
N=24 --> 12 Recruiting --> Completed